J. Macoin, R. Lissilaa, P. Sancheti, V. Reddy, J. Back, and G. Wolff, “Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses”, J of Skin, vol. 2, p. S62, Dec. 2018.